Axiom Space and TUA – 
Suborbital Testing of Insulin Pens

This experiment serves as a stepping stone to support astronauts with insulin-dependent diabetes and demonstrates a capability necessary for maintenance therapy and hyperglycemic states in insulindependent people with diabetes. This human-tended experiment includes two commercially available insulin pens, which will each be secured in a custom 3D-printed container during flight. During the flight, Tuva will retain the insulin pens in his flight suit, dial an insulin dose, and dispense insulin from each pen into a collection container to study the accuracy of dose dispensation in microgravity. Commercial spaceflight and the research flown on these missions are opening space to people with diabetes and those who previously have not been eligible to fly to space.